S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

VKTX Viking Therapeutics Inc

77.00

1.24 (1.64%)

May 03 2024 - Closed

Delayed by 15 minutes

Viking Therapeutics EPS in-line

To read the full story on Seeking Alpha, click here.

Viking Therapeutics (NASDAQ:VKTX)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Viking Therapeutics Charts.

Viking Therapeutics (NASDAQ:VKTX)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Viking Therapeutics Charts.

Viking Therapeutics Inc News

Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Wednesday 24 April 2024 (1 week ago) • PR Newswire (US)

U.S. Futures Display Mixed Results Amid Earnings, WTI and Brent Crude Prices Dip in June Futures Trading
Wednesday 24 April 2024 (1 week ago) • IH Market News

Viking Therapeutics to Report Financial Results for First Quarter 2024 on April 24, 2024
Wednesday 17 April 2024 (2 weeks ago) • PR Newswire (US)

Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of Dual GLP-1/GIP Receptor Agonist VK2735
Tuesday 26 March 2024 (1 month ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)

Viking Therapeutics Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters' Option to Purchase Additional Shares
Monday 4 March 2024 (2 months ago) • PR Newswire (US)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
Wednesday 28 February 2024 (2 months ago) • PR Newswire (US)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Tuesday 27 February 2024 (2 months ago) • Edgar (US Regulatory)

Viking Therapeutics Announces Proposed Public Offering of Common Stock
Tuesday 27 February 2024 (2 months ago) • PR Newswire (US)

More Viking Therapeutics Inc News Articles

Bell Buckle (PK)

Code Green Apparel (PK)

1812 Brewing (PK)

Moon Equity (PK)

Anavex Life Sciences

Good Vibrations Shoes (PK)

Digital Brand Media and ... (PK)

Voip Pal Com (QB)

AMC Entertainment

Intergrated Cannabis Sol... (PK)

Hannover House (PK)

Rennova Health (PK)

Trump Media and Technology

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions